Federal Register / Vol. 79, No. 213 / Tuesday, November 4, 2014 / Notices 65405 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1

Activity Number 

of respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average 

burden per 

response 

Total hours 

Justification Submitted as General Correspondence and in 

the Annual Report ............................................................ 2 1 2 16 32 

1There are no capital costs or operating and maintenance costs associated with this collection of information. 

Dated: October 28, 2014. 

Leslie Kux, 

Assistant Commissioner for Policy. 

[FR Doc. 2014–26140 Filed 11–3–14; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2010–N–0420] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Testing 

Communications on Food and Drug 

Administration-Regulated Products 

Used in Animals 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA) is announcing 

that a proposed collection of 

information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by December 

4, 2014. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–7285, or emailed to oira_

submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–0689. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Rd.; COLE–14526, Silver 

Spring, MD 20993–0002 PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Testing Communications on FDA/

Center for Veterinary Medicine (CVM)- 

Regulated Products Used in Animals 

(21 U.S.C. 393 (d)(2)(D))—OMB Control 

Number 0910–0689—Reinstatement 

FDA is authorized by section 

1003(d)(2)(D) of the Federal Food, Drug, 

and Cosmetic Act (21 U.S.C. 

393(d)(2)(D)) to conduct educational 

and public information programs 

relating to the safety of CVM-regulated 

products. FDA must conduct needed 

research to ensure that such programs 

have the highest likelihood of being 

effective. FDA expects that improving 

communications about the safety of 

regulated animal drugs, feed, food 

additives, and devices will involve 

many research methods, including 

individual indepth interviews, mallintercept interviews, focus groups, selfadministered surveys, gatekeeper 

reviews, and omnibus telephone 

surveys. 

The information collected will serve 

three major purposes. First, as formative 

research it will provide critical 

knowledge needed about target 

audiences to develop messages and 

campaigns about the use of FDAregulated products for use in animals. 

Knowledge of consumer and veterinary 

professional decision-making processes 

will provide the better understanding of 

target audiences that FDA needs to 

design effective communication 

strategies, messages, labels, and 

labeling. These communications will 

aim to improve public understanding of 

the risks and benefits of using regulated 

animal drugs, feed, food additives, and 

devices by providing users with a better 

context in which to place risk 

information more completely. 

Second, as initial testing, it will allow 

FDA to assess the potential effectiveness 

of messages and materials in reaching 

and successfully communicating with 

their intended audiences. Testing 

messages with a sample of the target 

audience will allow FDA to refine 

messages while still in the 

developmental stage. Respondents will 

be asked to give their reaction to the 

messages in either individual or group 

settings. 

Third, as evaluative research, it will 

allow FDA to ascertain the effectiveness 

of the messages and the distribution 

method of these messages in achieving 

the objectives of the message campaign. 

Evaluation of campaigns is a vital link 

in continuous improvement of 

communications at FDA. 

In the Federal Register of June 16, 

2014 (79 FR 34312) FDA published a 60- 

day notice requesting public comment 

on the proposed collection of 

information. One comment was 

submitted; however, it was not 

responsive to the four collection of 

information topics solicited and 

therefore is not discussed in this 

document. 

FDA estimates the burden of this 

collection of information based on 

recent prior experience with the various 

types of data collection methods 

described in this document: 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1

21 U.S.C. 393(d)(2)(D) Number of 

respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average 

burden per 

response 

Total hours 

Individual Indepth Interviews ............................................... 360 1 360 0.75 270 

General Public Focus Group Interviews .............................. 288 1 288 1.5 432 

Intercept Interviews: Central Location ................................. 600 1 600 0.25 150 

Intercept Interviews: Telephone ........................................... 2 10,000 1 10,000 0.08 800 

Self-Administered Surveys ................................................... 2,400 1 2,400 0.25 600 


rmajette on DSK3VPTVN1PROD with NOTICES
65406 Federal Register / Vol. 79, No. 213 / Tuesday, November 4, 2014 / Notices 

TABLE 1—ESTIMATED ANNUAL REPORTING BURDEN 1—Continued 

21 U.S.C. 393(d)(2)(D) Number of 

respondents 

Number of 

responses per 

respondent 

Total annual 

responses 

Average 

burden per 

response 

Total hours 

Gatekeeper Reviews ............................................................ 400 1 400 0.50 200 

Omnibus Surveys ................................................................. 2,400 1 2,400 0.17 408 

Total (General Public) .......................................................... 16,448 ........................ 16,448 ........................ 2,860 

Veterinarian/Scientific Expert Focus Group Interviews ....... 288 1 288 0.75 216 

Total (Veterinarians/Scientific Experts) ................................ 288 1 288 ........................ 216 

Total (Overall) ............................................................... 16,736 1 16,736 ........................ 3,076 

1There are no capital costs or operating or maintenance costs associated with this collection of information. 

2These are brief interviews with callers to test message concepts and strategies following their call-in request to an FDA Center 1–800 

number. 

Annually, FDA projects about 30 

studies with 16,736 respondents, using 

a variety of research methods and 

lasting an average of 0.17 hours each 

(varying from 0.08–1.5 hours). 

Dated: October 28, 2014. 

Leslie Kux, 

Assistant Commissioner for Policy. 

[FR Doc. 2014–26141 Filed 11–3–14; 8:45 am] 

BILLING CODE 4164–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Food and Drug Administration 

[Docket No. FDA–2013–N–1161] 

Agency Information Collection 

Activities; Submission for Office of 

Management and Budget Review; 

Comment Request; Food Safety 

Survey 

AGENCY: Food and Drug Administration, 

HHS. 

ACTION: Notice. 

SUMMARY: The Food and Drug 

Administration (FDA or we) is 

announcing that a proposed collection 

of information has been submitted to the 

Office of Management and Budget 

(OMB) for review and clearance under 

the Paperwork Reduction Act of 1995. 

DATES: Fax written comments on the 

collection of information by December 

4, 2014. 

ADDRESSES: To ensure that comments on 

the information collection are received, 

OMB recommends that written 

comments be faxed to the Office of 

Information and Regulatory Affairs, 

OMB, Attn: FDA Desk Officer, FAX: 

202–395–7285, or emailed to oira_

submission@omb.eop.gov. All 

comments should be identified with the 

OMB control number 0910–0345. Also 

include the FDA docket number found 

in brackets in the heading of this 

document. 

FOR FURTHER INFORMATION CONTACT: FDA 

PRA Staff, Office of Operations, Food 

and Drug Administration, 8455 

Colesville Road, COLE–14526, Silver 

Spring, MD 20993–0002, PRAStaff@

fda.hhs.gov. 

SUPPLEMENTARY INFORMATION: In 

compliance with 44 U.S.C. 3507, FDA 

has submitted the following proposed 

collection of information to OMB for 

review and clearance. 

Food Safety Survey—(OMB Control 

Number 0910–0345)—Reinstatement 

I. Background 

Under section 903(b)(2) of the Federal 

Food, Drug, and Cosmetic Act (21 U.S.C. 

393(b)(2)), we are authorized to conduct 

research relating to foods and to 

conduct educational and public 

information programs relating to the 

safety of the nation’s food supply. The 

Food Safety Survey measures 

consumers’ knowledge, attitudes, and 

beliefs about food safety. Previous 

versions of the survey were collected in 

1988, 1993, 1998, 2001, 2006, and 2010. 

Data from the previous Food Safety 

Surveys and from this proposed survey 

will be used to evaluate two Healthy 

People 2020 objectives: (1) Increase the 

proportion of consumers who follow 

key food safety practices (Objective FS– 

5) and (2) reduce severe allergic 

reactions to food among adults with a 

food allergy diagnosis (Objective FS–4) 

(Ref. 1). Data from this survey will also 

be used to measure progress toward the 

United States Department of 

Agriculture’s Food Safety Inspection 

Service’s Fiscal Year 2011-Fiscal Year 

2016 Strategic Plan goal of ensuring 

that, ‘‘Consumers, including vulnerable 

and underserved populations, adopt 

food safety best practices’’ (Ref. 2). 

Additionally, Food Safety Survey data 

are used to measure trends in consumer 

food safety habits including hand and 

cutting board washing, cooking 

practices, and use of food thermometers. 

Finally, data are used to evaluate 

educational messages and to inform 

policymakers about consumer attitudes 

about technologies such as food 

irradiation and biotechnology. 

The proposed Food Safety Survey will 

contain many of the same questions and 

topics as previous Food Safety Surveys 

to facilitate measuring trends in food 

safety knowledge, attitudes, and 

behaviors over time. The proposed 

survey will also be updated to explore 

emerging consumer food safety topics 

and expand understanding of previously 

asked topics. For example, recent papers 

in both the United States (Ref. 3) and 

Europe (Refs. 4 and 5) have pointed to 

changing epidemiology of listeriosis 

where adults over 60 years old have the 

highest rates of the illness. One reason 

for the increase in listeriosis rates 

among those over 60 years old could be 

increasing host susceptibility due to 

widened use of immunocompromising 

medications. We plan to include 

questions on the proposed survey to 

document the proportion of those over 

60 years old who self-report taking a 

defined list of major 

immunocompromising medications. In 

conjunction with our established 

questions about safe food handling and 

eating potentially risky foods, the 

additional questions will expand our 

understanding of listeriosis among those 

over 60. Other new topics planned to be 

covered on the survey include: 

Consumer understanding of 

mechanically tenderized beef, 

awareness of foodborne pathogens such 

as Toxoplasma gondii, and awareness of 

the risks associated with eating raw 

sprouts. 

The methods for the proposed Food 

Safety Survey will be largely the same 

as those used with the previous Food 

Safety Surveys. One major difference is 

that, unlike the data collection mode for 

previous Food Safety Surveys that used 

only land telephone lines, the proposed 

survey will include cell phones in 

addition to landlines. A nationally 

representative sample of 4,000 adults 


rmajette on DSK3VPTVN1PROD with NOTICES